Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Oken

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|July 1, 1995
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphomaJ J Mazza, J D Hines, J W Andersen, et al.
Leukemia & Lymphoma|October 8, 1999
Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?P R Greipp, M C Trendle, T Leong, et al.
The New England Journal of Medicine|November 5, 1992
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphomaR V Smalley, J W Andersen, M J Hawkins, et al.
Seminars in Oncology|June 1, 1985
High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology GroupJ D Hines, J J Mazza, M M Oken, et al.
Haematology and Blood Transfusion|January 1, 1990
Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemiaJ M Rowe, J J Mazza, J D Hines, et al.
Blood|July 1, 1997
Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trialN E Kay, T Leong, R A Kyle, et al.
The American Journal of Medicine|August 1, 1985
Association between urinary zinc excretion and lymphocyte dysfunction in patients with lung cancerJ I Allen, E Bell, M G Boosalis, et al.
Leukemia|August 15, 2000
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology GroupS Lee, M S Tallman, M M Oken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology GroupH S Hochster, M M Oken, J N Winter, et al.
Cancer Investigation|January 1, 1990
Phase II trial of methylglyoxal-bis(guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) studyJ N Winter, P S Ritch, S T Rosen, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|July 1, 1995
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphomaJ J Mazza, J D Hines, J W Andersen, et al.
Leukemia & Lymphoma|October 8, 1999
Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?P R Greipp, M C Trendle, T Leong, et al.
The New England Journal of Medicine|November 5, 1992
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphomaR V Smalley, J W Andersen, M J Hawkins, et al.
Seminars in Oncology|June 1, 1985
High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology GroupJ D Hines, J J Mazza, M M Oken, et al.
Haematology and Blood Transfusion|January 1, 1990
Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemiaJ M Rowe, J J Mazza, J D Hines, et al.
Blood|July 1, 1997
Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trialN E Kay, T Leong, R A Kyle, et al.
The American Journal of Medicine|August 1, 1985
Association between urinary zinc excretion and lymphocyte dysfunction in patients with lung cancerJ I Allen, E Bell, M G Boosalis, et al.
Leukemia|August 15, 2000
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology GroupS Lee, M S Tallman, M M Oken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology GroupH S Hochster, M M Oken, J N Winter, et al.
Cancer Investigation|January 1, 1990
Phase II trial of methylglyoxal-bis(guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) studyJ N Winter, P S Ritch, S T Rosen, et al.
Pageof 15